查看購物車
  • Simplified Chinese
  • English
  • Japanese
2021-2031年亞太地區顱腦植入物市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1843354

2021-2031年亞太地區顱腦植入物市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 201 Pages | 訂單完成後即時交付

價格

亞太地區顱骨植入物市場預計將大幅成長，到 2031 年將達到約 4.3654 億美元，高於 2023 年的 2.484 億美元，預測期內的年複合成長率(CAGR) 為 7.3%。

執行摘要和市場分析

亞太地區被公認為全球成長最快的顱腦植入物市場。該市場涵蓋多個國家，包括中國、日本、印度、韓國、澳洲以及亞太地區的其他地區。中國、印度和日本是該市場擴張的主要動力，主要原因是老齡人口成長和神經系統疾病發生率上升。預計這些因素將在未來幾年推動市場成長。此外，政府措施和非政府組織的宣傳活動也進一步增強了市場活力。日本、中國和印度等國眾多產業參與者的存在也對市場發展發揮至關重要的作用。

市場區隔分析

亞太地區顱骨植入物市場可根據類型、材料和應用進行細分：

  • 依類型：市場分為頂骨植入物、額骨植入物、枕骨植入物、顳骨植入物和蝶骨植入物。 2023年，頂骨植入物佔據了最大的市場。
  • 依材質：細分包括聚甲基丙烯酸甲酯、聚醚醚酮、鈦等，其中聚醚醚酮在 2023 年佔據市場主導地位。
  • 按最終用戶分類：市場分為醫院、創傷中心和其他，其中醫院在 2023 年佔據最大佔有率。

市場展望

3D列印技術（又稱積層製造）的出現正在徹底改變顱骨植入物的生產方式。該技術能夠製造高度客製化、針對特定患者的植入物，與傳統方案相比，其貼合度和功能性均更佳。能夠精確複製個體顱骨幾何形狀，從而減少手術併發症並改善復健效果。此外，3D列印中多層技術的整合，使得能夠生產具有不同特性的植入物，以滿足特定功能需求，例如結構強度和生物相容性。這項創新改善了骨整合，最大限度地降低了植入物排斥的風險，並增強了對大腦的保護。

3D列印還能縮短生產時間，降低製造成本，並增強對複雜顱骨畸形的適應性。這些進步不僅改善了患者的治療效果，也使顱骨植入物更容易被更廣泛的患者群體所接受。因此，多層技術與3D列印的結合為顱骨植入物市場帶來了巨大的成長機會。

國家洞察

亞太地區顱骨植入物市場主要涵蓋中國、日本、印度、韓國、澳洲等國家，其中中國在2023年佔最大市場佔有率。根據2023年發布的一項研究，中國報告指出2020年40歲以上人口的中風發生率為340萬，盛行率為1780萬。每年約有200萬人首次經歷中風，其中相當一部分人無法獨立生活。顱骨植入物在中風治療和復健的應用日益廣泛，有助於術後保護和重建顱骨，同時可能有助於運動功能的恢復。

此外，中國創傷性腦損傷 (TBI) 發生率不斷上升，估計每年新增病例約 772,800 至 892,800 例，這推動了顱腦植入物的需求。中國社會經濟的快速發展、環境挑戰、生活方式的改變以及城鎮化進程為健康維護帶來了挑戰。政府的「健康中國2030」規劃綱要強調了健康對經濟成長的重要性，並大力投資醫療基礎設施和技術，旨在提高醫療服務的可及性和品質。這些措施為顱腦植入物市場創造了有利的環境。

公司簡介

亞太地區顱骨植入物市場的主要參與者包括史賽克公司 (Stryker Corp)、捷邁邦美控股公司 (Zimmer Biomet Holdings Inc)、Integra 生命科學控股公司 (Integra LifeSciences Holdings Corp)、OsteoMed SA、Anatomics Pty Ltd、Matrix Surgical Holdings LLC 等。這些公司正在採取各種策略，例如擴張、產品創新和併購，以提升其市場影響力，並為消費者提供創新解決方案。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：亞太地區顱骨植入物市場概況

  • 概述
  • PEST分析

第5章：亞太顱骨植入物市場－關鍵市場動態

  • 亞太顱骨植入物市場－關鍵市場動態
  • 市場促進因素
    • 創傷性腦損傷盛行率上升
    • 老年人口激增
  • 市場限制
    • 植入物失敗的風險
  • 市場機會
    • 融入原創多層技術的3D列印技術進步
  • 未來趨勢
    • 客製化植入物
  • 促進因素和限制因素的影響：

第6章：亞太地區顱骨植入物市場 - 分析

  • 2021-2031年亞太地區顱腦植入物市場收入
  • 亞太地區顱骨植入物市場預測分析

第7章：亞太地區顱骨植入物市場分析－依類型

  • 頂葉
  • 額葉
  • 枕骨
  • 顳
  • 蝶骨

第8章：亞太地區顱骨植入物市場分析－依材料

  • 聚甲基丙烯酸甲酯
  • 聚醚醚酮
  • 鈦
  • 其他

第9章：亞太地區顱骨植入物市場分析－依最終用戶

  • 醫院
  • 創傷中心
  • 其他

第 10 章：亞太地區顱骨植入物市場 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 11 章：產業格局

  • 概述
  • 併購
  • 產品發布
  • 擴張和其他策略發展

第12章：公司簡介

  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • Integra LifeSciences Holdings Corp
  • OsteoMed SA
  • Anatomics Pty Ltd
  • Matrix Surgical Holdings LLC
  • Calavera Surgical
  • Medtronic Plc
  • Xilloc Medical BV
  • Johnson & Johnson
  • evonos GmbH & Co. KG
  • B Braun SE
  • UAB Ortho Baltic
  • 3D Systems Corp
  • GPC Medical Ltd
  • Bioplate Inc
  • EUROS SAS
  • Biocomposites Ltd
  • Medprin Biotech GmbH
  • Kelyniam Global Inc
  • MedCAD
  • KLS Martin Group
  • Longeviti Neuro Solutions LLC

第 13 章：附錄

Product Code: BMIRE00031982

The Asia Pacific cranial implants market is projected to grow significantly, reaching approximately US$ 436.54 million by 2031, up from US$ 248.40 million in 2023, with a compound annual growth rate (CAGR) of 7.3% during the forecast period.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as the fastest-growing market for cranial implants globally. This market encompasses several countries, including China, Japan, India, South Korea, Australia, and other regions within Asia Pacific. Key contributors to the market's expansion include China, India, and Japan, driven by an increasing elderly population and a rise in neurological disorders. These factors are expected to propel market growth in the coming years. Additionally, government initiatives and awareness campaigns by non-governmental organizations are further enhancing market dynamics. The presence of numerous industry players in countries like Japan, China, and India also plays a crucial role in the market's development.

Market Segmentation Analysis

The Asia Pacific cranial implants market can be segmented based on type, material, and application:

  • By Type: The market is divided into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants held the largest market share.
  • By Material: The segmentation includes polymethyl methacrylate, polyether ether ketone, titanium, and others, with polyether ether ketone leading the market in 2023.
  • By End User: The market is categorized into hospitals, trauma centers, and others, where hospitals accounted for the largest share in 2023.

Market Outlook

The advent of 3D printing technology, also known as additive manufacturing, is revolutionizing the production of cranial implants. This technology allows for the creation of highly customized, patient-specific implants that offer better fit and functionality compared to traditional options. The ability to replicate an individual's skull geometry precisely reduces surgical complications and enhances recovery outcomes. Furthermore, the integration of multilayer technology in 3D printing enables the production of implants with varying properties tailored for specific functions, such as structural strength and biocompatibility. This innovation improves osseointegration, minimizes the risk of implant rejection, and provides enhanced protection for the brain.

3D printing also facilitates faster production times, lowers manufacturing costs, and offers greater adaptability to complex cranial deformities. These advancements not only enhance patient outcomes but also make cranial implants more accessible to a wider patient demographic. Consequently, the integration of multilayer technology in 3D printing presents significant opportunities for growth in the cranial implant market.

Country Insights

The Asia Pacific cranial implants market includes key countries such as China, Japan, India, South Korea, Australia, and others, with China holding the largest market share in 2023. According to a study published in 2023, China reported a stroke incidence of 3.4 million and a prevalence of 17.8 million among individuals aged 40 and above in 2020. Each year, around 2 million people experience their first stroke, with a significant percentage unable to live independently. Cranial implants are increasingly utilized in stroke treatment and rehabilitation, serving to protect and reconstruct the skull post-surgery while potentially aiding in motor function recovery.

Moreover, the rising incidence of traumatic brain injuries (TBIs) in China, estimated at approximately 772,800 to 892,800 new cases annually, is driving demand for cranial implants. The rapid socioeconomic development, environmental challenges, lifestyle changes, and urbanization in China pose health maintenance obstacles. The government's Healthy China 2030 Plan highlights the importance of health for economic growth, with substantial investments in healthcare infrastructure and technology aimed at improving access and quality. These initiatives create a favorable environment for the cranial implants market.

Company Profiles

Key players in the Asia Pacific cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, and others. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Cranial Implants Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Asia Pacific Cranial Implants Market - Key Market Dynamics

  • 5.1 Asia Pacific Cranial Implants Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increase in Prevalence of Traumatic Brain Injuries
    • 5.2.2 Surge in Elderly Populations
  • 5.3 Market Restraints
    • 5.3.1 Risk of Implant Failure
  • 5.4 Market Opportunities
    • 5.4.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
  • 5.5 Future Trends
    • 5.5.1 Customized Implants
  • 5.6 Impact of Drivers and Restraints:

6. Asia Pacific Cranial Implants Market - Analysis

  • 6.1 Asia Pacific Cranial Implants Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Cranial Implants Market Forecast Analysis

7. Asia Pacific Cranial Implants Market Analysis - by Type

  • 7.1 Parietal
    • 7.1.1 Overview
    • 7.1.2 Parietal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Frontal
    • 7.2.1 Overview
    • 7.2.2 Frontal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Occipital
    • 7.3.1 Overview
    • 7.3.2 Occipital: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Temporal
    • 7.4.1 Overview
    • 7.4.2 Temporal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Sphenoid
    • 7.5.1 Overview
    • 7.5.2 Sphenoid: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Cranial Implants Market Analysis - by Material

  • 8.1 Polymethyl Methacrylate
    • 8.1.1 Overview
    • 8.1.2 Polymethyl Methacrylate: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Polyether Ether Ketone
    • 8.2.1 Overview
    • 8.2.2 Polyether Ether Ketone: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Titanium
    • 8.3.1 Overview
    • 8.3.2 Titanium: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Cranial Implants Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Trauma Centers
    • 9.2.1 Overview
    • 9.2.2 Trauma Centers: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Cranial Implants Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Cranial Implants Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Asia Pacific Cranial Implants Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.2.2 China: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.2.3 China: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.3 Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Japan: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.3.2 Japan: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.3.3 Japan: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.4 India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.4.2 India: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.4.3 India: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.5 Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Australia: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.5.2 Australia: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.5.3 Australia: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.6 South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 South Korea: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.6.2 South Korea: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.6.3 South Korea: Asia Pacific Cranial Implants Market Share - by End User
      • 10.1.1.7 Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of APAC: Asia Pacific Cranial Implants Market Share - by Type
        • 10.1.1.7.2 Rest of APAC: Asia Pacific Cranial Implants Market Share - by Material
        • 10.1.1.7.3 Rest of APAC: Asia Pacific Cranial Implants Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Mergers and Acquisitions
  • 11.3 Product Launch
  • 11.4 Expansions and Other Strategic Developments

12. Company Profiles

  • 12.1 Stryker Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Zimmer Biomet Holdings Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Integra LifeSciences Holdings Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 OsteoMed SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Anatomics Pty Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Matrix Surgical Holdings LLC
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Calavera Surgical
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Xilloc Medical BV
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Johnson & Johnson
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 evonos GmbH & Co. KG
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 B Braun SE
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 UAB Ortho Baltic
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 3D Systems Corp
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 GPC Medical Ltd
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 Bioplate Inc
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 EUROS SAS
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments
  • 12.18 Biocomposites Ltd
    • 12.18.1 Key Facts
    • 12.18.2 Business Description
    • 12.18.3 Products and Services
    • 12.18.4 Financial Overview
    • 12.18.5 SWOT Analysis
    • 12.18.6 Key Developments
  • 12.19 Medprin Biotech GmbH
    • 12.19.1 Key Facts
    • 12.19.2 Business Description
    • 12.19.3 Products and Services
    • 12.19.4 Financial Overview
    • 12.19.5 SWOT Analysis
    • 12.19.6 Key Developments
  • 12.20 Kelyniam Global Inc
    • 12.20.1 Key Facts
    • 12.20.2 Business Description
    • 12.20.3 Products and Services
    • 12.20.4 Financial Overview
    • 12.20.5 SWOT Analysis
    • 12.20.6 Key Developments
  • 12.21 MedCAD
    • 12.21.1 Key Facts
    • 12.21.2 Business Description
    • 12.21.3 Products and Services
    • 12.21.4 Financial Overview
    • 12.21.5 SWOT Analysis
    • 12.21.6 Key Developments
  • 12.22 KLS Martin Group
    • 12.22.1 Key Facts
    • 12.22.2 Business Description
    • 12.22.3 Products and Services
    • 12.22.4 Financial Overview
    • 12.22.5 SWOT Analysis
    • 12.22.6 Key Developments
  • 12.23 Longeviti Neuro Solutions LLC
    • 12.23.1 Key Facts
    • 12.23.2 Business Description
    • 12.23.3 Products and Services
    • 12.23.4 Financial Overview
    • 12.23.5 SWOT Analysis
    • 12.23.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 List of Abbreviations

List Of Tables

  • Table 1. Asia Pacific Cranial Implants Market Segmentation
  • Table 2. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Material
  • Table 5. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 9. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 10. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 12. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 13. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 15. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 18. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 20. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 21. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 22. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 23. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 24. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 25. List of Abbreviations

List Of Figures

  • Figure 1. Asia Pacific Cranial Implants Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Cranial Implants Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Cranial Implants Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Parietal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Frontal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Occipital: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Temporal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Sphenoid: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Asia Pacific Cranial Implants Market Share (%) - by Material (2023 and 2031)
  • Figure 12. Polymethyl Methacrylate: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Polyether Ether Ketone: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Titanium: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Cranial Implants Market Share (%) - by End User (2023 and 2031)
  • Figure 17. Hospitals: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Trauma Centers: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Cranial Implants Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)